Scarica l'app Stockscreener
37.52
1.49%
0.5016
Kodiak Sciences Inc Borsa (KOD) Ultime notizie
Is Kodiak Sciences’ (KOD) Shift Into Russell Growth Indices Reframing Its Core Investment Story? - Sahm
Form 4 Kodiak Sciences Inc For: 2 July By Investing.com - Investing.com Canada
Kodiak Sciences (KOD) director receives grant of 17,731 stock options - Stock Titan
Director at Kodiak Sciences (KOD) receives 17,731 stock options award - Stock Titan
[Form 4] Kodiak Sciences Inc. Insider Trading Activity - Stock Titan
17,731 options granted to Kodiak (NASDAQ: KOD) board director - Stock Titan
Kodiak Sciences (KOD) director awarded stock options for 17,731 shares at $38.96 - Stock Titan
17,731 Kodiak Sciences (KOD) options granted tied to Baker funds - Stock Titan
Why Did KOD Stock Surge To A Four-Year High Today? - Stocktwits
KOD News | KODIAK SCIENCES INC (NASDAQ:KOD) - ChartMill
Kodiak Sciences Inc Q1 2026 Earnings: EPS Beat Despite Zero Revenue, Stock Gains 3.23%Earnings Call Transcript - dars.gov.et
Kodiak Sciences Inc.(NasdaqGM:KOD) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
LifeSci Capital Maintains Kodiak Sciences(KOD.US) With Buy Rating, Maintains Target Price $65 - Moomoo
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell 2000 Value Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM:KOD) dropped from Russell Microcap Value Benchmark Index - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) added to Russell 2000 Growth Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) added to Russell 3000E Growth Benchmark - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell 3000E Index - marketscreener.com
Kodiak Sciences Inc.(NasdaqGM: KOD) dropped from Russell Microcap Index - marketscreener.com
Enterprise value to EBIT forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Enterprise value to EBITDA forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to book forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Enterprise value to revenue forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Price to earnings forward of Kodiak Sciences Inc – NASDAQ:KOD - TradingView
Kodiak Sciences, Inc. Actuals & Estimates (NASDAQ:KOD) - TradingView
KOD Forecast — Price Target — Prediction for 2027 - TradingView
KODKodiak Sciences Inc Options - Finviz
KODIAK SCIENCES INC (KOD) Stock Chart - ChartMill
Kodiak Sciences Inc (KOD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kodiak Sciences Inc (KOD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kodiak Sciences Inc (KOD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kodiak Sciences Inc (KOD) Institutional Confidence - TradingKey
Kodiak Sciences Inc (KOD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kodiak Sciences Inc (KOD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kodiak Sciences Inc (KOD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kodiak Sciences Inc (KOD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kodiak Sciences Inc (KOD) Valuation: PE, PB & Fair Value Analysis - TradingKey
KOD Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline Progress Temps Market SkepticismEarnings Decline Risk - newsline.com
Kodiak Sciences Inc Stock (US50012K1051): Quiet-day stock in focus after no fresh trigger was verifi - Ad-hoc-news.de
Kodiak Sciences: Clinical Redemption Is Turning Into Platform Leverage (NASDAQ:KOD) - Seeking Alpha
Kodiak Sciences (KOD) Edges Higher: Biotech Momentum Builds at $34.55ATR Stop - newsline.com
Kodiak stock rises 35% in 3 months: Here's what you need to know - MSN
Kodiak Sciences Inc. - MLQ.ai
Why Kodiak Sciences (KOD) Is Down 15.4% After Zenkuda’s Phase III GLOW2 Win And Accelerated Filing - Sahm
Kodiak Sciences Zenkuda Trial Win Puts Cash Needs And Growth In Focus - Sahm
Kodiak Sciences (KOD) Is Down 15.4% After Strong Zenkuda GLOW2 Data And Accelerated Filing Plans - Yahoo Finance
Kodiak Sciences CFO John Borgeson sold $1.02 million in NASDAQ:KOD shares By Investing.com - Investing.com South Africa
Kodiak Sciences CFO John Borgeson sold $1.02 million in NASDAQ:KOD shares - Investing.com Nigeria
Kodiak (KOD) CFO sells 30,000 shares under 10b5-1 trading plan - Stock Titan
Kodiak Sciences Inc. (KOD) Presents at Jefferies Global Healthcare Conference 2026Slideshow - Seeking Alpha
Kodiak Sciences Inc. Files Form 8-K with SEC Detailing Company and Stock Information (June 2026) - Minichart
Kodiak Sciences Stockholders Back Directors and Governance Proposals - TipRanks
Kodiak Sciences (NASDAQ: KOD) 2026 meeting approves all proposals - Stock Titan
KOD (NASDAQ: KOD) scheduled sale of 30,000 shares after option exercise - Stock Titan
Kodiak Stock Rises 35% in 3 Months: Here's What You Need to Know - The Globe and Mail
Kodiak Sciences CEO to present at 2026 Jefferies Global Healthcare Conference on June 4 - Pluang
Kodiak Sciences Stock Rises Above Key Support as Biotech Sector Shows Mixed SignalsZigzag Correction - dars.gov.et
Kodiak Sciences to Present at 2026 Jefferies Global Healthcare Conference - 富途牛牛
Kodiak Sciences CEO to speak at 2026 Jefferies healthcare event - Stock Titan
Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally - AOL.com
1.60%
3.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):